Platinum Turmeric
Turmeric 95% + glucosamine + chondroitin + bromelain. The anti-inflammatory-joint stack.
Clinical-dose precision. No taste, no mixing, no fuss.
Premium ingredient list on paper: 95% curcuminoids, glucosamine + chondroitin pairing, boswellia, bromelain. But none of the doses are disclosed. Classed as "premium" by the label, but until we see the dose panel, we can't score it there.
- Includes
- Turmeric (95% Curcuminoids) not disclosed · Glucosamine Sulfate 2KCl not disclosed · Chondroitin Sulfate not disclosed · Boswellia Extract not disclosed · MSM not disclosed · BioPerine not disclosed · Ginger Root Extract not disclosed · Quercetin Dihydrate not disclosed · Bromelain not disclosed
- Supply
- 30 servings · re-ship every 30 or 60 days
- Tested by
- Third-party tested · COA on request
- Reviewed by
- Licensed PharmD · clinical advisory team
- Shipping
- Free US shipping · Made in Colorado · 3 business days
Build the habit. Skip any month.
Testing and quality
- GMPcGMPManufactured in a current Good Manufacturing Practice facility.
- 3PT3rd-partyIdentity, potency, and contaminant testing by an independent lab.
Every molecule, graded.
A · EVIDENCE: STRONG
B · EVIDENCE: MODERATE
Why this formula.
We pick ingredients by effect size, not marketing. Each citation below links the strongest available human evidence — with the honest limitations noted.
“Turmeric (95% Curcuminoids) at the clinical dose, and what the trials show.”
not disclosed — the dose used in the strongest available randomized evidence. See the ingredient page for full methodology and pooled effect sizes.
“Glucosamine Sulfate 2KCl at the clinical dose, and what the trials show.”
not disclosed — the dose used in the strongest available randomized evidence. See the ingredient page for full methodology and pooled effect sizes.
“Chondroitin Sulfate at the clinical dose, and what the trials show.”
not disclosed — the dose used in the strongest available randomized evidence. See the ingredient page for full methodology and pooled effect sizes.
